05/17/2023 — , a hormone made by the pancreas , helps the glucose in your blood get into your cells to be used for energy. Another hormone, glucagon , works with insulin to control
10/25/2022 — diabetes Criteria patients with fulminant 1 diabetes Inclusion Criteria: 1) diabetic ketosis or ketoacidosis occurred soon after the onset of hyperglycemic symptoms; 2
01/13/2023 — department with abdominal pain and diabetes cardinal features (polyuria, polydipsia, vomiting). Blood tests demonstrated hyperglycemia >800 mg/dL, capillary ketonemia >3 mmol
10/21/2022 — specifically asked to call if they have hypoglycemia (blood sugar <70 mg/dl) or hyperglycemia (blood sugar >250 mg/dl) on more than one occasion. Study Intervention Visit 1
05/11/2023 — Abstract Summary Fulminant type 1 diabetes (FT1D) is a subtype of diabetes characterized by rapid progression of β-cell destruction, hyperglycemia, and diabetic
12/07/2022 — (T1D), also known as insulin-dependent diabetes mellitus or diabetes mellitus type 1, is an autoimmune disease that results from the destruction of insulin-producing
01/23/2023 — 1 diabetes is an autoimmune condition in which the immune system sees the pancreas as a virus and therefore fights off the insulin that it produces. Without insulin
05/02/2023 — glucose tolerance who are at high risk for developing T1DM and have antibodies suggesting an immunological attack on their pancreas. A 14-day infusion of the drug prevents T
03/13/2023 — Susceptibility Genetic Predisposition to Disease Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune Diseases Immune System Diseases Disease Attributes Pathologic Processes To Top
12/05/2022 — . At the beginning of disease progression, the number of beta cells in the pancreas covers the need for insulin and the only sign of the disease at this early stage is the
04/21/2023 — daily insulin dose and improve glycemic variability without increasing risk of severe hypoglycemia or diabetic ketoacidosis in adults with type 1 diabetes. Study Design
05/09/2023 — Inclusion Criteria: Diagnosis of T1D for at least 1 year based on clinical presentation (polyuria, polydipsia, weight loss, and/or ketoacidosis, or with positive diabetes
11/22/2022 — glucose, circulating insulin concentrations in the blood, and changes in liver metabolite accumulation. Even with a modest level of supplementation, the fiber-rich additives
04/03/2023 — Brief Summary: The aim of this study is to compare the glycemic and metabolic control of type 1 diabetic patients in replacement therapy with insulin, comparing those
03/13/2023 — -promising breast cancer drug candidate. Sanofi, maker of long acting insulin products Toujeo and Lantus for type 2 diabetes, in 2019 quit further type 2 diabetes drug
11/21/2022 — That Can Delay Onset of Type 1 Diabetes. FDA News Release. November 17, 2022. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-can-delay-onset-type-1-diabetes
11/24/2022 — ) is a multifactorial autoimmune disease characterized by T-cell-mediated destruction of insulin-producing β-cells of the pancreas. T1D is the most commonly diagnosed
02/22/2023 — terms Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune Diseases Immune System Diseases To Top
04/29/2023 — Biomedical Engineering , using one of the alginate formulations to encapsulate human insulin-secreting islet cells provided long-term blood sugar level control in diabetic
04/01/2023 — β-cell loss and the “accelerators” such as insulin resistance, β-cell autoimmunity, and genetic background. Regardless of the type of diabetes, finally comes with total
02/23/2023 — function in recently-diagnosed type 1 diabetes. When type 1 diabetes is first diagnosed, the pancreas is still able to make small amounts of insulin, which helps control
12/15/2022 — of type 1-diabetes continuous monitoring and spot-like monitoring. Moreover, hypoglycemia (low level of glucose concentration) can be easily avoided by the use of
02/04/2023 — diabetes distress. The artificial pancreas or closed-loop system connects these devices via a control algorithm programmed to maintain target glucose, partially relieving
12/11/2022 — Type one Diabetes Mellitus is an autoimmune condition characterized by insulin deficiency and hyperglycemia in people with underlying genetic susceptibility. The
11/29/2022 — MeSH terms Diabetes Mellitus Diabetes Mellitus, Type 1 Hypoglycemia Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune
05/04/2023 — between Rhyper and Rhypo suggests an individual behavioral characteristic toward intensive correction of glucose excursions. Keywords: continuous glucose monitoring; rebound hyperglycemia; rebound hypoglycemia; type 1 diabetes mellitus.
01/27/2023 — , continuous glucose monitoring (CGM) technology and automated insulin delivery. However, long-term optimal glycemic control is still only achieved in a minority. Areas covered
03/16/2023 — randomized controlled trial, children aged 2 to 5 years with type 1 diabetes were randomly assigned, 2:1, to the t:slim X2 insulin pump with Control-IQ (Tandem Diabetes Care) plus
10/21/2022 — dysregulation may change with disease duration. Post-prandial hyperglycemia adds to glucose variability, difficulty with insulin dosing and overall instability of glucose control
04/26/2023 — administered while previous doses are still active in the body; insulin stacking is a known cause of hypoglycemia [ 49 ]. In a similar sense, a CGM user may observe their glucose
04/14/2023 — diagnosed with Type 1 diabetes with poor glycemic control in the 13-18 age group on metabolic control of adolescents. Condition or disease Intervention/treatment Phase 13
01/12/2023 — for controlling blood sugar levels. All people with type 1 diabetes require insulin therapy to survive. People with type 2 diabetes have insulin resistance and
04/14/2023 — diagnosed with type 1 diabetes. “Use of an automated insulin delivery system started shortly after diagnosis is beneficial in improving glucose levels even though it does not
11/18/2022 — · type 2 – where the body does not produce enough insulin, or the body’s cells do not react to insulin Type 2 diabetes is far more common than type 1. Saad Baig captain’s
03/06/2023 — Diabetes Mellitus, Type 1 Pediatric Obesity Overweight Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Overnutrition Nutrition Disorders Body Weight Autoimmune Diseases Immune System Diseases To Top
02/16/2023 — binding; +1, high binding). (D) mRNA expression levels associated with the progression of diabetic nephropathy. These genes are involved in pathways including insulin
03/21/2023 — distribution, cases of COVID-19 infection, mean diabetes duration, BMI, HbA1c, insulin dose, and glucose metrics ( Table 1 ). Viral vector-based vaccine After 7 days of the first
10/19/2022 — insulin delivery systems, also called artificial pancreas or closed-loop control systems, track a person’s blood glucose levels using a continuous glucose monitor and
03/28/2023 — to Share IPD: No Additional relevant MeSH terms: Layout table for MeSH terms Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune Diseases Immune System Diseases To Top
03/29/2023 — diabetes whose pancreas is still producing some insulin. “As with many studies, the results answer one question but raise many other questions that will need to be addressed
05/17/2023 — Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune Diseases Immune System Diseases Insulin Insulin, Globin Zinc Antioxidants
05/01/2023 — Nature Biomedical Engineering , using one of the alginate formulations to encapsulate human insulin-secreting islet cells provided long-term blood sugar level control in
02/21/2023 — [ Time Frame: 3 months ]Type 1 Diabetes Distress Scale. Higher scores indicate more diabetes distress, with a range from 1 to 6. Diabetes Distress [ Time Frame: 6 months
03/01/2023 — levels and restored glucose-responsive insulin secretion in three nonhuman primates with type 1 diabetes for as long as the animals were tested. "The achievement of
04/03/2023 — variability, and hypoglycemia confidence in persons with type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technol Ther . 2018;20(4):274–284. PMID
01/27/2023 — the disease, the body’s own immune response destroys beta cells in the pancreas so that the body can no longer produce insulin. People with type 1 diabetes need to take
05/05/2023 — , Helsinki, Finland Editorial on the Research Topic Revisiting cellular metabolism and type 1 diabetes Type 1 diabetes (T1D) is a chronic autoimmune condition characterized by
12/27/2022 — variable oral intake and activity. For some, poor glycaemic control leads to frequent and prolonged inpatient admissions. The use of technology, such as flash glucose
04/08/2023 — attack, the method normalized blood glucose levels and restored glucose-responsive insulin secretion in three nonhuman primates with type 1 diabetes for as long as the animals
05/24/2023 — relevant MeSH terms: Layout table for MeSH terms Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune Diseases Immune System Diseases To Top
12/29/2022 — />[0040] The term “diabetes” is used interchangeably with diabetes mellitus and encompasses Type 1 Diabetes, both autoimmune and idiopathic, and Type 2 diabetes. The World
05/26/2023 — glucose levels to whom Pembrolizumab is being administered should be done along with the history of any other PD-1/PD-L1 inhibitor that was administered before. Keywords: Pembrolizumab, Immunotherapy, Endocrine dysfunction, Type I diabetes.
02/01/2023 — diabetes (stage 1 of type 1 diabetes) within a few years. About a year before the onset of the disease, they can then see disturbances in the blood sugar pattern with stress
03/23/2023 — ages 6 and up with Type 1 diabetes based on two earlier studies. The Control-IQ artificial pancreas system. (Credit: Tandem Diabetes Care) “After the resounding success of
02/06/2023 — serious hypoglycemia. “ Hybrid closed-loop systems seem to help young children with type 1 diabetes to reach better glycemic control and ease the burden of diabetes from
02/15/2023 — diabetes population , specifically among female adolescents. Most striking differences are seen regarding glycemic control, BMI, insulin dose, DKA and quality of life,” the
02/27/2023 — aged 2 to 5 years who had type 1 diabetes for at least 3 months, were users of an insulin pump and a Dexcom continuous glucose monitor, and had a daily insulin dose of at
01/05/2023 — terms Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune Diseases Immune System Diseases To Top
02/09/2023 — until there is a cure. The diabetes educator taught me how to check my sugar, draw up insulin, and give myself a shot. She taught me the warning signs of high and low blood
05/24/2023 — Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Autoimmune Diseases Immune System
11/16/2022 — quality for the study if you have Type 1 diabetes, use an insulin pump and are between the ages of 18-60 years old. Subjects will be reimbursed for time and travel. For
05/18/2023 — Biomedical Engineering , using one of the alginate formulations to encapsulate human insulin-secreting islet cells provided long-term blood sugar level control in diabetic mice
03/11/2023 — body stops producing insulin –the hormone needed to transport sugar away from the blood and into cells to be used for energy. This differs from the more common type 2
12/01/2022 — Enteral ACE2 Prevents Diabetic Retinopathy in Type 1 Diabetes Ram Prasad # 1 , Jason L Floyd # 1 , Mariana Dupont 1 , Angela Harbour 1 , Yvonne Adu Aggyeiwaah 1
05/02/2023 — retinopathy and nephropathy after the onset of type 1 diabetes mellitus: Contribution of glycemic control and metabolic memory]. Bolotskaya LL, Bessmertnaya EG, Shestakova MV
03/24/2023 — progression. During the coronavirus disease 2019(COVID-19) pandemic, cases of hyperglycemia, diabetic ketoacidosis (DKA), and new diabetes increased, suggesting that severe